Helga Weber

776 total citations
28 papers, 562 citations indexed

About

Helga Weber is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Helga Weber has authored 28 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Surgery and 8 papers in Oncology. Recurrent topics in Helga Weber's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer Mechanisms and Therapy (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Helga Weber is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer Mechanisms and Therapy (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Helga Weber collaborates with scholars based in Chile, Germany and Sweden. Helga Weber's co-authors include Juan Carlos Roa, Patricia García, Pamela Leal, Ismael Riquelme, Carolina Bizama, Jaime A. Espinoza, Bruno Nervi, Óscar Tapia, Alejandra Sandoval and Miguel Villaseca and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Helga Weber

25 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helga Weber Chile 13 343 150 119 117 101 28 562
Malcolm Mason United Kingdom 14 315 0.9× 151 1.0× 80 0.7× 214 1.8× 43 0.4× 28 670
Joung Eun Lim South Korea 12 314 0.9× 143 1.0× 124 1.0× 138 1.2× 45 0.4× 20 577
Venkat R. Katkoori United States 15 342 1.0× 243 1.6× 199 1.7× 72 0.6× 122 1.2× 34 621
Magdy Sayed Aly Egypt 14 235 0.7× 91 0.6× 106 0.9× 95 0.8× 117 1.2× 44 644
Lu Hao China 13 321 0.9× 131 0.9× 123 1.0× 63 0.5× 36 0.4× 50 548
Teng‐Kuei Hsu United States 8 381 1.1× 212 1.4× 213 1.8× 39 0.3× 54 0.5× 9 644
Michio Maemura Japan 17 205 0.6× 247 1.6× 158 1.3× 88 0.8× 136 1.3× 72 662
Anna Woloszynska‐Read United States 18 593 1.7× 163 1.1× 141 1.2× 102 0.9× 97 1.0× 32 875
Leping Yang China 17 398 1.2× 195 1.3× 229 1.9× 117 1.0× 49 0.5× 41 725

Countries citing papers authored by Helga Weber

Since Specialization
Citations

This map shows the geographic impact of Helga Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helga Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helga Weber more than expected).

Fields of papers citing papers by Helga Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helga Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helga Weber. The network helps show where Helga Weber may publish in the future.

Co-authorship network of co-authors of Helga Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Helga Weber. A scholar is included among the top collaborators of Helga Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helga Weber. Helga Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reyes, María Elena, Helga Weber, Álvaro Gutiérrez, et al.. (2024). In Vitro Effect of Epigallocatechin Gallate on Heme Synthesis Pathway and Protoporphyrin IX Production. International Journal of Molecular Sciences. 25(16). 8683–8683. 1 indexed citations
2.
Gutiérrez, Álvaro, Helga Weber, Ramón Silva, et al.. (2023). Abstract 2845: PpIX synthesis increases PDT resistant cells due to the modulating effect of EGCG on the heme synthesis pathway. Cancer Research. 83(7_Supplement). 2845–2845. 1 indexed citations
3.
Weber, Helga, Gareth I. Owen, Pablo Ernesto Pérez, et al.. (2023). Advances towards the use of gastrointestinal tumor patient-derived organoids as a therapeutic decision-making tool. Biological Research. 56(1). 63–63. 6 indexed citations
4.
Bizama, Carolina, Jun Zhong, Kurt Buchegger, et al.. (2023). A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance. International Journal of Molecular Sciences. 24(8). 7238–7238. 3 indexed citations
5.
Effer, Brian, Francisca Muñoz, Diego M. Bustos, et al.. (2023). Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging. Biomedicines. 11(7). 2086–2086. 12 indexed citations
6.
Núñez-Montero, Kattia, et al.. (2022). Bacteria and Boar Semen Storage: Progress and Challenges. Antibiotics. 11(12). 1796–1796. 14 indexed citations
7.
8.
García, Patricia, Carolina Bizama, Jaime A. Espinoza, et al.. (2020). Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor. Biological Research. 53(1). 13–13. 4 indexed citations
9.
García, Patricia, Sergio L. Vargas, Helga Weber, et al.. (2020). Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer. Cancers. 12(4). 778–778. 26 indexed citations
10.
Schartner, Christoph, Christiane Ziegler, Miriam A. Schiele, et al.. (2016). Hypomethylation of corticotropin releasing hormone receptor 1 promoter region: Converging evidence for a role in panic disorder. European Neuropsychopharmacology. 26. S593–S593. 1 indexed citations
11.
Bizama, Carolina, Patricia García, Jaime A. Espinoza, et al.. (2015). Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy. Cancer Treatment Reviews. 41(3). 222–234. 48 indexed citations
12.
Schneider, H., et al.. (2015). Aluminum-Free Intestinal Phosphate Binding. Contributions to nephrology. 38. 32–36.
13.
Riquelme, Ismael, Kathleen Saavedra, Jaime A. Espinoza, et al.. (2015). Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget. 6(28). 24750–24779. 105 indexed citations
14.
Ili, Carmen, Priscilla Brebi, Patricia García, et al.. (2015). Effects of c-FLIPL Knockdown in Cervical Uterine Carcinoma Cell Lines. International Journal of Morphology. 33(2). 638–646.
15.
Tapia, Óscar, Ismael Riquelme, Pamela Leal, et al.. (2014). The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(1). 25–33. 160 indexed citations
16.
Wichmann, Christian, Linping Chen-Wichmann, Helga Weber, et al.. (2014). Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitors. Leukemia. 29(2). 279–289. 36 indexed citations
17.
Roa, Juan Carlos, et al.. (2013). AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines. OncoTargets and Therapy. 6. 1373–1373. 21 indexed citations
18.
Schneider, Helen, et al.. (1985). Aluminum-free oral phosphate binder.. PubMed. 24 Suppl 1. S98–102.
19.
Stern, Fritz, et al.. (1974). Das Scheitern illiberaler politik : Studien zur politischen Kultur Deutschlands im 19. und 20. Jahrhundert. 1 indexed citations
20.
Mietens, C & Helga Weber. (1966). A syndrome characterized by corneal opacity, nystagmus, flexion contracture of the elbows, growth failure, and mental retardation. The Journal of Pediatrics. 69(4). 624–629. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026